(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Disease Models, Animal

(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium has been researched along with Disease Models, Animal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, H; Cheng, PW; Iwakawa, J; Seki, M	1

Other Studies

1 other study(ies) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Disease Models, Animal

Article	Year
p53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft, using transferrin-facilitated lipofection gene delivery strategy. Human gene therapy, 2002, Apr-10, Volume: 13, Issue:6 Topics: Animals; beta-Galactosidase; Cholesterol; Disease Models, Animal; Gene Expression; Gene Transfer Techniques; Genetic Therapy; Humans; In Situ Nick-End Labeling; Lipids; Liposomes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phosphoric Monoester Hydrolases; Prostatic Neoplasms; PTEN Phosphohydrolase; Quaternary Ammonium Compounds; Staining and Labeling; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2002

Article

Year

p53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft, using transferrin-facilitated lipofection gene delivery strategy.

Human gene therapy, 2002, Apr-10, Volume: 13, Issue:6

Topics: Animals; beta-Galactosidase; Cholesterol; Disease Models, Animal; Gene Expression; Gene Transfer Techniques; Genetic Therapy; Humans; In Situ Nick-End Labeling; Lipids; Liposomes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phosphoric Monoester Hydrolases; Prostatic Neoplasms; PTEN Phosphohydrolase; Quaternary Ammonium Compounds; Staining and Labeling; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2002